Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chiauranib in ≥2nd-line small cell lung cancer
CTR20210658Phase 3Completed
- Sponsor
- Akeso, Inc.
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chiauranib in small cell lung cancer (SCLC), sponsored by Akeso, Inc.. Started Apr 2021; status: completed.
02
Drugs
chiauranib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on CTR20210658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210658.